
Laura R Glick
Articles
-
Apr 22, 2024 |
jamanetwork.com | Joshua D. Wallach |Samuel Yoon |Harry Doernberg |Laura R Glick
Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments Key PointsQuestion What is the strength of association between surrogate markers used as primary end points in clinical trials to support Food and Drug Administration (FDA) approval of drugs treating nononcologic chronic diseases and clinical outcomes?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →